IL6 and rheumatoid arthritis: Therefore, the present study aimed to determine whether hsa-miR-137 effects inflammation in RA and the results revealed that the overexpression of hsa-miR-137 substantially decreased the expression of IL-6 and COX-II in RA-FLS, suggesting that hsa-miR-137 may have potential as an anti-inflammatory therapy for RA.